We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Approximately one-third to two-thirds of ...

Patient-reported outcomes (PROs) in rheumatology are not just personal lists of physical complaints or so-called "organ recitals." In fact, PROs can both guide treatment decisions in daily practice ...

About one-third of patients prefer in-hospital administration, particularly if they are older or already make frequent visits to the hospital. Most patients with rheumatoid arthritis (RA) would prefer ...

Patients with RA and cancer desire personalized information on RA therapies' impact on cancer outcomes, highlighting the need for clear communication. Gaps in clarity about drug interactions and ...

Patients with rheumatoid arthritis (RA) who received immune checkpoint inhibitors (ICIs) for cancer had no increased risk for mortality and showed no differences in cause of death compared with ...

Please provide your email address to receive an email when new articles are posted on . The future of rheumatoid arthritis treatment has expanded beyond just managing the disease itself, according to ...

It's well established that gum disease and rheumatoid arthritis (RA) are strongly linked. But what wasn't known, until a ...

In a recent study published in RMD Open, researchers assessed cognitive function among rheumatoid arthritis (RA) patients with ongoing inflammatory activity. Study: Impact of inflammation on cognitive ...

For most rheumatoid arthritis (RA) patients on stable medical therapy, blood tests for drug toxicity may be unnecessary after the first 6 months, researchers concluded. Beyond 6 months, most new and ...

Regular blood testing to check for toxicity from standard rheumatoid arthritis drugs is recommended. However, guidelines are vague as to how frequently and for how long such testing should occur.